Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$195.32	$14,280,742,110
	22,362,850	$195.32	$4,367,911,862
	17,233,668	$195.32	$3,366,080,034
	14,567,176	$195.32	$2,845,260,817
	9,033,726	$195.32	$1,764,467,363
	8,998,338	$195.32	$1,757,555,379
	8,322,140	$195.32	$1,625,480,385
	8,009,729	$195.32	$1,564,460,269
	7,619,135	$195.32	$1,488,169,449
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Sep 18, 2023 04:20PM Form SC 13D/A Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Sep 14, 2023 09:23PM Form 4 Ikena Oncology, Inc. For: Aug 04 Filed by: ORBIMED ADVISORS LLC
Sep 14, 2023 04:21PM Form SC 13D/A Ikena Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Sep 6, 2023 07:00AM Exome Asset Management Names Alex Forschner and Joseph Narvaez to Corporate Office
Sep 5, 2023 04:20PM Form SC 13D/A Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 30, 2023 05:08PM Form 144 Galecto, Inc. Filed by: OrbiMed Advisors Israel II Ltd
Aug 30, 2023 05:03PM Form 144 Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 30, 2023 04:57PM Form 144 Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 23, 2023 04:57PM Form SC 13D/A PMV Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Aug 21, 2023 08:15PM Form 144/A Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 21, 2023 04:57PM Form 144 Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 21, 2023 04:55PM Form 144 Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 21, 2023 04:40PM Form 144 Galecto, Inc. Filed by: OrbiMed Advisors Israel II Ltd
Aug 17, 2023 04:31PM Form SC 13D/A Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 15, 2023 06:26PM Form 144 Galecto, Inc. Filed by: OrbiMed Advisors Israel II Ltd
Aug 15, 2023 06:23PM Form 144 Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 15, 2023 06:20PM Form 144 Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 15, 2023 06:00AM SINOVAC Reports Unaudited First Half of 2023 Financial Results
Aug 14, 2023 04:25PM Form 13F-HR ORBIMED ADVISORS LLC For: Jun 30
Aug 11, 2023 04:24PM Form SC 13D/A Gracell Biotechnologies Filed by: ORBIMED ADVISORS LLC
Aug 3, 2023 05:00PM Form SC 13D/A Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
Aug 2, 2023 05:03PM Form SC 13D/A Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 31, 2023 06:36PM Form 144 Galecto, Inc. Filed by: OrbiMed Advisors Israel II Ltd
Jul 31, 2023 06:32PM Form 144 Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 31, 2023 06:30PM Form 144 Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 25, 2023 04:58PM Form 144 Galecto, Inc. Filed by: OrbiMed Advisors Israel II Ltd
Jul 25, 2023 04:55PM Form 144 Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 25, 2023 04:52PM Form 144 Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 24, 2023 04:38PM Form 4 Turnstone Biologics Corp For: Jul 20 Filed by: ORBIMED ADVISORS LLC
Jul 24, 2023 04:34PM Form SC 13D Turnstone Biologics Corp Filed by: ORBIMED ADVISORS LLC
Jul 20, 2023 09:46PM Form 3 Turnstone Biologics Corp For: Jul 20 Filed by: ORBIMED ADVISORS LLC
Jul 19, 2023 04:12PM Form SC 13D/A Theseus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Jul 17, 2023 04:12PM Form SC 13D/A Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 13, 2023 08:10PM Form 144 Galecto, Inc. Filed by: OrbiMed Advisors Israel II Ltd
Jul 13, 2023 08:05PM Form 144 Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 13, 2023 08:01PM Form 144 Galecto, Inc. Filed by: ORBIMED ADVISORS LLC
Jun 29, 2023 04:42PM Form 4 Passage BIO, Inc. For: Jun 27 Filed by: ORBIMED ADVISORS LLC
Jun 29, 2023 04:37PM Form SC 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Jun 29, 2023 04:30PM Form SC 13D/A Adicet Bio, Inc. Filed by: ORBIMED ADVISORS LLC
Jun 21, 2023 04:54PM Form SC 13D/A Disc Medicine, Inc. Filed by: ORBIMED ADVISORS LLC
Jun 15, 2023 04:35PM Form 144 Gracell Biotechnologies Filed by: ORBIMED ADVISORS LLC
Jun 13, 2023 01:57PM LSI USA Emerging Medtech Summit Returns to Dana Point March 18, 2024
May 24, 2023 04:57PM Form SC 13D VectivBio Holding AG Filed by: ORBIMED ADVISORS LLC
May 24, 2023 04:54PM Form SC 13D/A Prelude Therapeutics Filed by: ORBIMED ADVISORS LLC
May 17, 2023 04:47PM Form SC 13D/A SpringWorks Therapeutics Filed by: ORBIMED ADVISORS LLC
May 16, 2023 04:29PM Form SC 13D/A Fusion Pharmaceuticals Filed by: ORBIMED ADVISORS LLC
May 16, 2023 04:25PM Form SC 13D/A Verona Pharma plc Filed by: ORBIMED ADVISORS LLC
May 15, 2023 06:08PM Form 4 Verona Pharma plc For: May 11 Filed by: ORBIMED ADVISORS LLC
May 15, 2023 04:42PM Form 13F-HR ORBIMED ADVISORS LLC For: Mar 31
May 11, 2023 06:18PM Form 144 Verona Pharma plc Filed by: ORBIMED ADVISORS LLC

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed